Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. https://doi.org/10.3390/jcm10112235

Article  PubMed  PubMed Central  Google Scholar 

Iorio R (2024) Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Rev Neurol 20:84–98. https://doi.org/10.1038/s41582-023-00916-w

Article  CAS  PubMed  Google Scholar 

Cavalcante P, Mantegazza R, Antozzi C (2024) Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis. Front Immunol 15:1404191. https://doi.org/10.3389/fimmu.2024.1404191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaminski HJ, Sikorski P, Coronel SI, Kusner LL (2024) Myasthenia gravis: the future is here. J Clin Invest. https://doi.org/10.1172/JCI179742

Article  PubMed  PubMed Central  Google Scholar 

Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP, Yu CY (2023) The complement system and human autoimmune diseases. J Autoimmun 137:102979. https://doi.org/10.1016/j.jaut.2022.102979

Article  CAS  PubMed  Google Scholar 

Huang YF, Sandholm K, Persson B, Nilsson B, Punga AR (2024) Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis. Muscle Nerve 70:851–861. https://doi.org/10.1002/mus.28227

Article  CAS  PubMed  Google Scholar 

Dalakas MC (2022) Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis. Expert Rev Clin Immunol 18:691–701. https://doi.org/10.1080/1744666X.2022.2082946

Article  CAS  PubMed  Google Scholar 

Ling M, Murali M (2019) Analysis of the complement system in the clinical immunology laboratory. Clin Lab Med 39:579–590. https://doi.org/10.1016/j.cll.2019.07.006

Article  PubMed  Google Scholar 

Rawish E, Sauter M, Sauter R, Nording H, Langer HF (2021) Complement, inflammation and thrombosis. Br J Pharmacol 178:2892–2904. https://doi.org/10.1111/bph.15476

Article  CAS  PubMed  Google Scholar 

West EE, Woodruff T, Fremeaux-Bacchi V, Kemper C (2024) Complement in human disease: approved and up-and-coming therapeutics. Lancet 403:392–405. https://doi.org/10.1016/S0140-6736(23)01524-6

Article  CAS  PubMed  Google Scholar 

Gavriilaki E, de Latour RP, Risitano AM (2022) Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond. Blood 139:3571–3582. https://doi.org/10.1182/blood.2021012860

Article  CAS  PubMed  Google Scholar 

Zheng R, Zhang Y, Zhang K, Yuan Y, Jia S, Liu J (2022) The complement system, aging, and aging-related diseases. Int J Mol Sci. https://doi.org/10.3390/ijms23158689

Article  PubMed  PubMed Central  Google Scholar 

Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, Simone S, Gesualdo L, Battaglia M, Ditonno P, Lucarelli G (2023) Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma. Int J Mol Sci. https://doi.org/10.3390/ijms242216515

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Tao L, Su H (2022) The complement system in metabolic-associated kidney diseases. Front Immunol 13:902063. https://doi.org/10.3389/fimmu.2022.902063

Article  CAS  PubMed  PubMed Central  Google Scholar 

DonadoCA, Theisen E, Zhang F, Nathan A, Fairfield ML, Rupani KV, Jones D, Johannes KP, RASLEN. Accelerating Medicines Partnership, Raychaudhuri S, Dwyer DF, Jonsson AH, Brenner MB (2025) Granzyme K activates the entire complement cascade. Nature. https://doi.org/10.1038/s41586-025-08713-9

Albazli K, Kaminski HJ, Howard JF Jr (2020) Complement inhibitor therapy for myasthenia gravis. Front Immunol 11:917. https://doi.org/10.3389/fimmu.2020.00917

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P (2020) Complement Inhibition for the Treatment of Myasthenia Gravis. Immunotargets Ther 9:317–331. https://doi.org/10.2147/ITT.S261414

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evoli A, Spagni G, Monte G, Damato V (2021) Heterogeneity in myasthenia gravis: considerations for disease management. Expert Rev Clin Immunol 17:761–771. https://doi.org/10.1080/1744666X.2021.1936500

Article  CAS  PubMed  Google Scholar 

Liu PY, Li HQ, Dong MQ, Gu XY, Xu SY, Xia SN, Bao XY, Xu Y, Cao X (2023) Infiltrating myeloid cell-derived properdin markedly promotes microglia-mediated neuroinflammation after ischemic stroke. J Neuroinflammation 20:260. https://doi.org/10.1186/s12974-023-02946-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ozawa Y, Uzawa A, Onishi Y, Yasuda M, Kojima Y, Kuwabara S (2023) Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies. Muscle Nerve 68:798–804. https://doi.org/10.1002/mus.27973

Article  CAS  PubMed  Google Scholar 

Theissen L, Schroeter CB, Huntemann N, Rauber S, Dobelmann V, Cengiz D, Herrmann A, Koch-Holsken K, Gerdes N, Hu H, Mourikis P, Polzin A, Kelm M, Hartung HP, Meuth SG, Nelke C, Ruck T (2024) Recombinant acetylcholine receptor immunization induces a robust model of experimental autoimmune myasthenia gravis in mice. Cells. https://doi.org/10.3390/cells13060508

Article  PubMed  PubMed Central  Google Scholar 

Howard JF Jr (2018) Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci 1412:113–128. https://doi.org/10.1111/nyas.13522

Article  CAS  PubMed  Google Scholar 

Xie CB, Jane-Wit D, Pober JS (2020) Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets. Am J Pathol 190:1138–1150. https://doi.org/10.1016/j.ajpath.2020.02.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanderson NSR (2022) Complement and myasthenia gravis. Mol Immunol 151:11–18. https://doi.org/10.1016/j.molimm.2022.08.018

Article  CAS  PubMed  Google Scholar 

Warwick CA, Keyes AL, Woodruff TM, Usachev YM (2021) The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain. J Biol Chem 297:101085. https://doi.org/10.1016/j.jbc.2021.101085

Article  CAS  PubMed  PubMed Central  Google Scholar 

West EE, Kemper C (2023) Complosome—the intracellular complement system. Nat Rev Nephrol 19:426–439. https://doi.org/10.1038/s41581-023-00704-1

Article  PubMed  Google Scholar 

Dziadkowiak E, Baczynska D, Waliszewska-Prosol M (2024) MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets. Cells. https://doi.org/10.3390/cells13060556

Article  PubMed  PubMed Central  Google Scholar 

Maslinska M, Dmowska-Chalaba J, Jakubaszek M (2021) The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol 12:787422. https://doi.org/10.3389/fimmu.2021.787422

Article  CAS  PubMed  Google Scholar 

Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J (2023) Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. Front Immunol 14:1212757.